pyrantel and febantel

The common anthelmintics used to treat parasitic infections of horses are described. Dosage, anthelmintic spectrum, formulation and administration, mode of action, toxicity contraindications, and resistance of parasites to anthelmintics are included.

Topics: Animals; Anthelmintics; Benzimidazoles; Guanidines; Horse Diseases; Horses; Ivermectin; Levamisole; Organophosphorus Compounds; Parasitic Diseases; Parasitic Diseases, Animal; Phenothiazines; Piperazines; Pyrantel; Strongyle Infections, Equine

Ancylostoma ceylanicum is a common hookworm of dogs, cats and humans in Asia. More recently, this hookworm was found to infect dogs in Australia. The objective of this study was to determine the efficacy of a combination product containing pyrantel, febantel and praziquantel (Drontal) Plus Flavour, Bayer) against A. ceylanicum in experimentally infected dogs. Twelve dogs were each subcutaneously injected with 300 infective third-stage larvae of A. ceylanicum. Pups were stratified by egg count and randomly allocated equally into control and treatment groups. The pups in the treatment group were treated orally at 20 days post-infection with a tablet containing pyrantel, febantel and praziquantel (Drontal Plus Flavour, Bayer) with the recommended dose of one tablet per 10 kg bodyweight. The dogs in the control group were not treated. Egg counts were performed daily until the end of the study period and compared for the treated and control groups. No eggs were detected in the treated group of pups within 3 days of treatment, and faecal samples from this group remained negative throughout the rest of the study resulting in a treatment efficacy (egg reduction) of 100% (p = 0.0011). The egg counts for the untreated group remained high for the rest of the study period. This trial demonstrated that a combination tablet containing pyrantel, febantel and praziquantel (Drontal Plus Flavour, Bayer) given at the manufacturer's recommended dose is effective against infection with A. ceylanicum in dogs.

Topics: Ancylostoma; Ancylostomiasis; Animals; Anthelmintics; Dog Diseases; Dogs; Drug Combinations; Feces; Guanidines; Parasite Egg Count; Praziquantel; Pyrantel; Treatment Outcome

Using routine coprological methods, 1161 faecal samples from animal shelters located in Madrid (Spain) were analysed, showing a 28% prevalence for different intestinal parasites: Giardia duodenalis (7%), Cystoisopora spp. (3.8%), Toxocara canis (7.8%), Toxascaris leonina (6.3%), Ancylostomidae (4%), Trichuris vulpis (3.3%), Taenidae (2.9%) and Dipylidium caninum (0.9%). The therapeutic efficacies of mebendazole at a dose of 22 mg/kg once daily for 3 days, fenbendazole at a dose of 50 mg/kg once daily for 3 days and a drug combination of febantel-pyrantel-praziquantel at a dose of 15-5-5 mg/kg once were valuated and compared by collecting faecal samples on days 9 and 16 post-treatment from naturally infected dogs in field-trial conditions. From the infected dogs (321 dogs), 150 animals were selected for the study. Distribution randomly divided the animals into three study groups of ten dogs per parasite and per treatment group: group A, mebendazole; group B, fenbendazole and group C, febantel-pyrantel-praziquantel. The therapeutic efficacy against ascarids and ancylostomids (days 9-16) was very high (75-100%) for the three groups: for T. canis, 100% in group A, 80-100% in group B, 97-100% in group C; for T. leonina, 98-100% in group A, 100% in group B, 92-94% in group C and for ancylostomids, 100% in group A, 99-100% in group B, 90-100% in group C. On the other hand, the highest efficacy against Taenidae infections was in group B (90-100%), followed by groups C (73-91%) and A (70-90%).

Topics: Animals; Anthelmintics; Dog Diseases; Dogs; Fenbendazole; Guanidines; Intestines; Mebendazole; Parasitic Diseases, Animal; Praziquantel; Pyrantel; Spain

This study evaluated the effect of two combination products containing febantel, pyrantel, and praziquantel (FPP) for the treatment of Giardia species in experimentally infected kittens. In experiment 1, five kittens were administered the United States (US) formulation of FPP at doses of 37.8 mg/kg, 7.56 mg/kg, and 7.56 mg/kg, respectively, PO, q24h, for 5 days and four kittens remained as controls. In experiment 2, five kittens were administered the European formulation of FPP at the doses of 12.5 mg/kg, 12 mg/kg, and 4.16 mg/kg, respectively, PO, q24h, for 5 days and four kittens remained as controls. In experiment 3, six kittens were administered the US formulation of FPP at 56.5 mg/kg, 11.3 mg/kg, 11.3 mg/kg, respectively, PO, q24h, for 5 days and five kittens remained as controls. Thirteen days after treatment, kittens testing negative for Giardia species cysts were administered 20 mg/kg methylprednisolone acetate, IM, weekly for a maximum of two injections. Feces were analyzed for Giardia species cysts using a direct immunofluorescence test. After experiment 3, four of the six treated kittens, but no control kittens, remained negative for Giardia species after the administration of methylprednisolone acetate.

Topics: Aging; Animals; Anthelmintics; Cat Diseases; Cats; Drug Combinations; Female; Giardiasis; Guanidines; Male; Praziquantel; Pyrantel; Tablets; Treatment Outcome

In the present study, we investigated the in vitro effects on the motility and morphology of tissues and organs of Toxocara canis of the two drug components of Drontal Plus and Welpan, pyrantel and fenbendazole (the active metabolite of the prodrug febantel), both alone and in combination. Although there was no significant difference observable between the effects of the single drugs and the drug combination on worm motility, the synergistic effect of pyrantel and fenbendazole was manifested by morphological alterations seen by light and electron microscopy. Thus, an earlier onset of damage to worm tissues and organs could be observed compared to the application of the individual drugs. In addition, a higher degree of damage and an increased number of vital organs were involved. There was dramatic, significantly greater and irreversible damage to the hypodermis, longitudinal muscle, intestine, nerve cords and genital organs induced by the pyrantel/fenbendazole combination. We hypothesise that these synergistic effects will also take place when dogs are treated either with Drontal Plus or Welpan in which lower dosages will be sufficient to destroy the worms.

Topics: Animals; Antinematodal Agents; Dog Diseases; Dogs; Drug Synergism; Fenbendazole; Guanidines; Male; Microscopy, Electron; Organ Specificity; Parasitic Sensitivity Tests; Pyrantel; Toxocara canis; Toxocariasis

Pyrantel embonate and febantel are both constituents of Drontal Plus and Drontal Puppy broad spectrum anthelmintics for dogs. The effects of pyrantel and the febantel metabolite fenbendazole were investigated against Toxocara canis in-vitro by studying changes in worm motility and tissue damage. Pyrantel and fenbendazole were added to worms incubated in media for 8 h at the following concentrations: pyrantel: 12.2 microg, 25 microg, or 50 microg; fenbendazole: 50 microg, 100 microg or 200 microg; mixture of pyrantel and fenbendazole: 12.2 microg p + 50 microg f, 25 microg p + 100 microg f, 50 microg p + 200 microg f. Following this 8 h incubation period, one group of the worms was immediately fixed and studied by light- and electron microscopical examination. Other groups have been observed for further 8 h periods up to 56 hours and then studied in the same way.

Topics: Animals; Antinematodal Agents; Drug Synergism; Fenbendazole; Guanidines; Microscopy, Electron, Scanning; Pyrantel; Toxocara canis

Fourteen of 23 dogs developing patent Trichuris vulpis infections by 120 days p.i. with 5000 embryonated eggs were allocated into three groups. One group was treated with flubendazole 220 mg chewable tablets (Flubenol) at the recommended dose regimen once daily for 3 days. The second group was given the recommended single treatment with a tablet containing 150 mg febantel, 144 mg pyrantel embonate and 50 mg praziquantel in combination (Drontal Plus). The third group remained untreated. All dogs were necropsied for worm counts 10 or 11 days after (first) treatment. No worms were recovered from the flubendazole treated dogs resulting in a significant worm count reduction of 100%. In contrast, 2 of 5 animals treated with the combination of febantel, pyrantel embonate and praziquantel remained infected; the geometric mean worm burden was reduced by 99.4% as compared to the control group but did not differ significantly from those of the controls.

Topics: Animals; Antinematodal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Guanidines; Male; Mebendazole; Praziquantel; Pyrantel; Tablets; Treatment Outcome; Trichuriasis; Trichuris

To determine efficacy of treatment with a combination febantel-praziquantel-pyrantel product, with or without vaccination with a commercial Giardia vaccine, in dogs with naturally occurring giardiasis.. Prospective trial.. 16 Beagles naturally infected with Giardia duodenalis.. During phase 1, 6 dogs were treated with the parasiticide for 3 days (4 were also vaccinated). Four weeks later, all 6 dogs were treated with the parasiticide again for 5 days and were bathed and moved to clean cages after the last treatment (phase 2). Nine dogs were treated with the parasiticide for 3 (n = 4) or 5 (5) days and bathed and moved to clean cages after the last treatment (phase 3). Fecal samples were collected twice weekly for 24 days after treatment and tested for cysts with a quantitative zinc sulfate flotation technique and for Giardia antigen with an immunoassay.. Dogs in phase 1 were all shedding cysts again by day 24. In phase 2, only 1 dog shed cysts after treatment, and shedding was transient (day 17). In phase 3, neither cysts nor antigen was detected in fecal samples from 2 of 4 dogs treated for 3 days and 4 of 5 dogs treated for 5 days. In 18 of 57 (31.6%) fecal samples, cysts were seen, but results of the immunoassay were negative.. Results suggest that when a combination febantel-praziquantel-pyrantel product is used to treat dogs with giardiasis, bathing and changing the environment after treatment may be more important in preventing recurrence than duration of treatment.

Topics: Animals; Anthelmintics; Antigens, Protozoan; Dog Diseases; Dogs; Drug Combinations; Feces; Female; Giardia; Giardiasis; Guanidines; Hygiene; Male; Praziquantel; Prospective Studies; Protozoan Vaccines; Pyrantel; Secondary Prevention; Tablets; Treatment Outcome; Vaccination

The present study proved that combined administration of pyrantel and febantel to Heterakis spumosa-infected mice yielded clear synergistic effects (seen in a quicker expulsion of the worms and a significant higher degree of worm degeneration), whereas the different doses of both drugs never reached the same efficacy, when given alone. It is concluded that the synergistic action of pyrantel and febantel on the functions of different organs of the parasites (muscle, nerve, inertine etc.) seen in the rodent model - also holds for the gut dwelling nematodes of the dog.

Topics: Animals; Antinematodal Agents; Ascaridida; Ascaridida Infections; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Guanidines; Male; Mice; Microscopy, Electron; Pyrantel

Treatment of buffalo calves (Bubalus bubalis) at different times after birth demonstrated that transmission of Toxocara vitulorum from the cow to the calf via milk occurs in all calves during the first 2 days after birth, decreases to 53% by 6 days, 10% by 8-9 days and 2% from Day 10 onwards. This may be because the larvae are no longer in the milk or because the calf has become resistant to the establishment of a new infection. The result also emphasizes the importance of mammary transmission of the parasite. Against immature parasites the efficacy of pyrantel and levamisole was 97%; febantel was 100% on one farm, only 35% on another; piperazine 42% and thiabendazole 35%. Santonin was ineffective in four calves. Against mature parasites the efficacy of pyrantel was 100%; febantel was 100% on one farm, only 35% on another; oral levamisole 83%; cutaneous levamisole 73%; oxfendazole 89%; and piperazine 57%. Nevertheless, piperazine reduced the infection to levels which were probably not pathogenic. In general, the efficacy against mature parasites was similar to that against immature parasites. Treatment of 10-16-day-old calves with an anthelmintic, which is effective against immature parasites, is recommended. This procedure greatly reduces contamination of the environment and also precludes the pathogenic effect of a large number of immature or mature parasites.

Topics: Animals; Anthelmintics; Benzimidazoles; Buffaloes; Female; Guanidines; Levamisole; Milk; Piperazine; Piperazines; Pyrantel; Santonin; Thiabendazole; Time Factors; Toxocariasis

In order to confirm benzimidazole resistance as recommended at a workshop of the Commission of the European Communities the isolate 'E' of cyathostome strongyles originating from a stud where benzimidazole resistance had been demonstrated by egg hatch tests and by egg count reduction tests was investigated in two series of critical tests. Each of 11 foals reared strongyle-free was infected with 130,000 third stage cyathostome larvae. One animal remained untreated, two pairs of foals were treated with paste formulations of the (pro)benzimidazoles cambendazole (20 mg/kg bodyweight) or febantel (6 mg/kg bodyweight) and two groups of three foals were given pastes containing the non-benzimidazole drugs pyrantel pamoate (19 mg/kg bodyweight) or ivermectin (0.2 mg/kg bodyweight) either at 101 days (trial 1) or at 59 to 62 days (trial 2) after infection. Strongyles were counted in faecal samples collected daily between treatment and post mortem examination five or seven days later and worm burdens were counted in the intestinal contents and mucosal digests. Nine species of the cyathostome subfamily were found in the infected foals. The numbers of luminal stages were reduced by only 3.1 and 20.2 (mean 7.9) per cent by cambendazole and by 13.6 and 32.8 (mean 21.3) per cent by febantel in the individual animals. However, pyrantel pamoate (93.6 to 98.2, mean 96.3 per cent reduction) and ivermectin (100 per cent reduction) were highly effective. These trials provide the first report of benzimidazole resistant Cylicostephanus poculatus anywhere in the world and demonstrate (pro)benzimidazole resistance in seven other species for the first time in Europe.

Topics: Animals; Anthelmintics; Benzimidazoles; Cambendazole; Drug Resistance; Feces; Guanidines; Horses; Intestine, Large; Ivermectin; Parasite Egg Count; Pyrantel; Pyrantel Pamoate; Strongyle Infections, Equine; Strongyloidea